Skip to main content

Table 4 Predictors of LDL-C goal attainment

From: First-line treatment patterns and lipid target levels attainment in very high cardiovascular risk outpatients

  Initial model Final model
  OR (95% CIs) P-value OR (95% CIs) P-value
Male gender 1.66 (0.88-3.13) 0.1 1.88 (1.03-3.44) 0.04
Age 1.02 (0.99-1.04) 0.3   
DM 0.92 (0.49-1.76) 0.8   
Smoking 0.62 (0.36-1.07) 0.09 0.57 (0.33-0.96) 0.04
CAD 1.34 (0.65-2.77) 0.4   
PAD 1.53 (0.65-3.58) 0.3   
Cerebrovascular disease 0.14 (0.02-1.004) 0.05 0.15 (0.02-1.14) 0.07
Baseline LDL-C (mg/dl) 0.99 (0.98-0.99) <0.001 0.99 (0.98-0.99) <0.001
Combined therapy with statin and ezetimibe 1.15 (0.56-2.34) 0.7   
Very high potency LDL-C lowering regimen 1.94 (0.84-4.49) 0.1 2.21(1.15-4.24) 0.02
  1. DM = diabetes mellitus, CAD = coronary artery disease, PAD = peripheral arterial disease, LDL-C = low density lipoprotein-cholesterol.